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Introduction  1 
Patients with life limiting illness may experience significant symptom burden 2 
associated with their disease necessitating the need for the addition of complex 3 
pharmacotherapy.[1]  This is often complicated by established medications used to treat co-4 
morbid conditions, or prevent adverse consequences of these conditions.  One such example 5 
is using medications to treat hypertension in life limiting illness.  Indeed, the prevalence of 6 
hypertension is strongly associated with age – with more than 50 per cent of those aged 60 7 
years of age having a diagnosis of high blood pressure.[2]  Given that the majority of people 8 
with a life limiting illness are over 60 years of age, the use of antihypertensive medication in 9 
this patient population is common.   Previous studies have shown that reducing blood 10 
pressure significantly decreases the probability of developing ischaemic heart disease and 11 
stroke, although the time till benefit of this is several years.[3]  This is problematic in the 12 
context of diminished life expectancy, as the time till benefit of the medication can often 13 
outweigh the remaining life expectancy of the patient, raising questions over the risk benefit 14 
ratio of treatment.   This is further complicated by the fact that some patients with life 15 
limiting illness experience symptoms of cachexia, early satiety and thus lose significant 16 
amounts of body weight.  Whilst this can have a negative impact on quality of life, the weight 17 
loss can also reduce a patient’s blood pressure, thus negating the need to use antihypertensive 18 
medication.  It is important, therefore, to review antihypertensive medication in the context of 19 
remaining life expectancy whist monitoring blood pressure vigilantly, to ensure that the 20 
medication is used safely and appropriately.  While previous studies have assessed the 21 
appropriateness of medication in the context of diminished life expectancy, there is no work 22 
specifically exploring blood pressure control and the use of antihypertensive medication in 23 
this patient population. 24 
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The objectives of this study were, therefore, to: (1) assess the prevalence of 25 
previously documented hypertension and associated blood pressure in a cohort of patients 26 
with life limiting illness; and, (2) assess the appropriateness of antihypertensive medication in 27 
this patient group. 28 
 29 
Ethical Approval 30 
 Full NHS ethical approval was not required for this work, as it was considered a 31 
service improvement study.  As such, the study was registered with, and approved by South 32 
Tyneside NHS Foundation Trust (approval number CA6178), UK. All data was managed in 33 
accordance with the Data Protection Act and the requirements of the Caldicott guardian were 34 
met.   35 
 36 
Methods 37 
Patients were included in the study if they were registered as part of the specialist 38 
palliative care day service at St Benedict's Hospice, based in the North of England, on the 4th 39 
August 2015, and had been attending the service for at least one week. Participants were 40 
excluded from the study if they were not part of the day service and attended another part of 41 
the hospice (e.g. the inpatient unit).  The average the life expectancy of patients attending day 42 
services was approximately 18 months.  To meet the study objectives, patient electronic 43 
hospital records were reviewed and data relating to patient gender, age, diagnosis, standing 44 
blood pressure (where available) and sitting blood pressure were extracted.  Medication data 45 
were also extracted from the electronic record, which included medication type, dose and 46 
formulation; medication data were classified according to British National Formulary (BNF) 47 
category.  The appropriateness of the antihypertensive medication was assessed by the 48 
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clinical team, which included a palliative medicine consultant and a clinical pharmacist, using 49 
a framework, as proposed by Holmes et al., that considered the following factors: remaining 50 
life expectancy of the patient, time until benefit of the treatment, goals of care and treatment 51 
targets.[4]  Any patient that was assessed to be using antihypertensive medication 52 
inappropriately was referred to the wider clinical team for further investigation. 53 
 54 
Results 55 
Fifty-four people met the inclusion criteria and were included in the study; no patients 56 
were excluded from the study. Participant characteristics are shown in Table 1.  Twenty-six 57 
(48.1%) patients had previously documented hypertension: the mean blood pressure for these 58 
patients was 122/65 mm Hg (SD 17.0/10.5), while for the normotensive patients it was 59 
122/73 (SD 21.0/11.6).  Standing blood pressure was taken in 11 patients: for patients 60 
previously documented with hypertension the mean standing blood pressure reading was 61 
95/55 mm Hg (SD 27.5/12.1), while for the normotensive patients, the mean was 125/70 mm 62 
Hg (30.8/16.0).  Thirteen (24.1%) patients had documented symptoms of postural 63 
hypotension (5 of which had a diagnosis of hypertension).  All of the patients with previously 64 
diagnosed hypertension were taking at least one antihypertensive medication: 19 were using 65 
1; 4 were using 2; and, 3 patients were using three medications.   66 
Of the 26 patients using antihypertensive medication, the clinical team (a palliative 67 
medicine consultant and clinical pharmacist) accessed that 25 were using the medication 68 
inappropriately; this could have resulted in clinical intervention to reduce or stop these 69 
medications. These medications were considered inappropriate given the current blood 70 
pressure readings and the remaining life expectancy of the patient.  The patient who was 71 
accessed as using their antihypertensive medication appropriately also had heart failure; they 72 
were an ACE inhibitor and a beta-blocker to manage their symptoms. 73 
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In terms of other medication with the potential to affect blood pressure control, 15 74 
patients were using at least one anticholinergic medication: tri-cyclic antidepressants were the 75 
most common, while other medication included nefopam and drugs used to treat urinary 76 
urgency/frequency (oxybutynin, tropsium, solifenacin, fesoterodine and tolterodine).  Only 77 
five patients with hypertension were using anticholinergic drugs, compared to ten 78 
normotensive patients.  Loop diuretics were used in 8 patients, while potassium sparing 79 
diuretics were used in 3 patients: all of these patients had a previous diagnoses of 80 
hypertension.  81 
 82 
Discussion 83 
The main findings of this study showed the majority of patients attending a specialist 84 
palliative care day service were inappropriately using their antihypertensive medication.  85 
Indeed, many patients had low blood pressure – with some having symptoms of postural 86 
hypotension or large differences between sitting and standing blood pressure.  Given the 87 
association with postural hypertension and the risk of falls, this potentially has implication for 88 
patient safety.[5]  Previous studies have shown that patients with life limiting illness 89 
commonly use preventative medication inappropriately in the context of their remaining life 90 
expectancy.[6]  Our study, however, is the first to assess and report patients’ blood pressure 91 
and shows that many patients with previously diagnosed hypertension have low blood 92 
pressure with an average value of 122/65 mm Hg (SD 17.0/10.5).  This finding is timely 93 
given that, for patients with limited life expectancy, a recent Canadian consensus guideline 94 
recommends a target systolic blood pressure of 160 to 190 mm Hg[7], while NICE currently 95 
state that, for patients with hypertension, the blood pressure target should be below 140/90 96 
mm Hg if aged under 80 years, or below 150/90 mm Hg if aged over 80 years, although we 97 
note there is no specific reference to patients with limited life expectancy.[2]  98 
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We would urge policy-makers to build on this and produce clear practical guidance 99 
outlining blood pressure thresholds in order to facilitate the appropriate and safe use of 100 
antihypertensive medication.  Indeed, a set of recommendations have recently been published 101 
that outline approaches to the deprescribing of medication in diminished life expectancy [8], 102 
while Scott and colleagues have provided a step-wise protocol to the deprescribing process 103 
[9]: these works could be applied to antihypertensive medication, but fall short of explaining 104 
when medication should actually be discontinued.  105 
In terms of the wider literature, it is not known how discontinuing antihypertensive 106 
medication in life limiting illness affects blood pressure or patient outcome in terms of 107 
mortality.  A recent study, by Moonen and colleagues, has shown that discontinuing 108 
antihypertensive medication in older people with mild cognitive deficits did not improve 109 
cognitive, psychological or general daily functioning, although systolic and diastolic blood 110 
pressures increased by and average of 7.36 and 2.63 respectively.[10]  This is significant 111 
progress, but given our work shows that antihypertensives are used inappropriately in patients 112 
with life limiting illness, it would be prudent to focus future trials in this area to establish 113 
evidence-based approaches to deprescribing medication.   114 
While we believe our results are important and have potential implications around 115 
developing deprescribing approaches for antihypertensive medication, we acknowledge the 116 
main limitation of this study is that retrospective data, recorded in patients’ medical notes, 117 
was used.  There could therefore, in theory, be errors in the blood pressure data, as the blood 118 
pressure recording process was not quality assured.  We also acknowledge that only patients 119 
from one centre were sampled and sample size was relatively small; it would be prudent for 120 
future studies to extend the number of participants by including other palliative care centres.  121 
Our results should, therefore, be interpreted with this in mind. 122 
 123 
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Conclusion 124 
The blood pressure for patients with previously documented hypertension who access 125 
specialist palliative care day services is commonly below the NICE target threshold of 140/90 126 
mm Hg (150/90 mm Hg for patients aged over 80 years).  The majority of these patients are 127 
prescribed antihypertensive medications inappropriately and should have their 128 
antihypertensive medications reviewed in the context of their original therapeutic goals 129 
taking into account their current blood pressure control.  130 
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Table 1. Study participant information 
Characteristic Frequency (%) 
Gender  
Male 24 (44.4) 
Female 30 (55.5) 
  
Age  
<51 years 5 (9.3%) 
51-60 years 10 (18.5%) 
61-70 years 8 (14.8) 
71-80 years 16 (29.6%) 
81-90 years 13 (24.1%) 
>90 years 2 (3.7%) 
  
Primary Diagnosis  
Non-malignant disease 14 (25.9) 
Malignant disease 40 (74.1) 
  
Antihypertensive agents  
ACE inhibitors 9 (16.7) 
Angiotensin II receptor antagonists 5 (9.3) 
Beta-blockers 16 (30.0) 
Calcium channel blockers 3 (5.6) 
Thiazide diuretics  3 (5.6) 
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